Liver donation is one of the few areas in organ transplantation where a living person can give part of an organ and expect both halves to function fully, because the liver regenerates. About 9,000 liver transplants are performed each year in the United States, using organs from both deceased and living donors, yet the waiting list consistently outpaces supply. Whether you are considering becoming a living donor, trying to understand the process a loved one faces, or simply curious about how a person can give away part of a vital organ and walk away healthy, the landscape of liver donation is broader and more nuanced than most people realize.
How Living Donation Works
In a living donor liver transplant, a surgeon removes a portion of a healthy person’s liver and implants it in the recipient. The donor’s remaining liver and the transplanted piece both regenerate, typically reaching close to their original functional volume within several months. This regeneration relies on a dense network of growth signals and cellular pathways that kick in almost immediately after surgery.
The evaluation before anyone is approved to donate is exhaustive. Imaging plays a central role: high-resolution CT scans map the liver’s blood vessels and bile ducts at least two branches deep into the organ. One study of potential donors found anatomic variants in the bile ducts in about 39% of candidates, in the arteries in 40%, in the portal veins in about 21%, and in the hepatic veins in roughly 44%.1PubMed. Evaluation of living liver donors with an all-inclusive 3D multi-detector row CT protocol These are not diseases; they are normal anatomical variations. But they matter enormously for surgical planning, because an artery or duct that branches in an unexpected spot can change how the surgeon divides the liver, or whether donation is feasible at all.2PubMed Central. Imaging Evaluation of Living Liver Donor Candidates: Techniques, Protocols, and Anatomy Beyond anatomy, doctors screen for liver fat (steatosis), underlying disease, and psychological readiness.
Right Lobe Versus Left Lobe
When donating to an adult recipient, surgeons typically take the right lobe of the donor’s liver, because it is larger and provides enough mass for the recipient’s body. For a child, the smaller left lateral segment is usually sufficient. This distinction shapes the risk profile for donors considerably.
A systematic review and meta-analysis comparing right-lobe and left-lobe living donors found that right-lobe donors were roughly 63% more likely to experience major complications.3PubMed. Right Lobe Versus Left Lobe Living Donor Liver Transplantation: A Systematic Review and Meta-analysis of Donor and Recipient Outcomes That sounds alarming in relative terms, but the absolute rates remain fairly low. There was no statistically significant difference in donor death between the two groups. On the recipient side, right-lobe grafts were associated with fewer cases of “small-for-size syndrome,” a condition where the transplanted liver piece is too small to meet the recipient’s metabolic needs, and recipients of right-lobe grafts had lower postoperative mortality.4PubMed. Right Lobe Versus Left Lobe Living Donor Liver Transplantation: A Systematic Review and Meta-analysis of Donor and Recipient Outcomes So the trade-off is real: the larger graft is better for the recipient but harder on the donor.
What Complications Donors Actually Face
Biliary complications, meaning problems with the bile ducts, are the most common source of trouble after living donor liver transplantation, affecting both donors and recipients.5PubMed Central. Spectrum of biliary complications following live donor liver transplantation Bile leaks and strictures (narrowing of the ducts) are the usual culprits. In a single-center review of 176 donor operations, the most common serious complications among right-lobe donors included bile leaks, intra-abdominal bleeding, and pleural effusions (fluid around the lungs).6PubMed. Complications after Living Donor Hepatectomy: Analysis of 176 Cases at a Single Center Most of these required procedural intervention but were not life-threatening.
The short-term surgical risks are generally understood. Where the picture gets murkier is in the years that follow. A comprehensive review of long-term outcomes concluded that mortality and serious complications appear low over the long haul, and unlike kidney donation, there have been no reports of donors developing advanced liver disease years later. Liver regeneration appears complete within a few years based on volume measurements. Donors also report high quality of life and do not regret donating.7PubMed Central. Long-Term Medical and Psychosocial Outcomes in Living Liver Donors However, that same review flagged that donors commonly report lingering physical symptoms, health concerns, psychological distress, and financial burdens. Some enduring lab abnormalities, particularly low platelet counts, have also been noted.8PubMed Central. Long-Term Medical and Psychosocial Outcomes in Living Liver Donors
A large Korean study offered a more sobering comparison. Matching living liver donors against healthy controls, it found that donors had roughly double the mortality rate and a higher incidence of liver failure, depression, cancer, diabetes, hypertension, stroke, and end-stage kidney disease.9PubMed. Outcomes of living liver donors are worse than those of matched healthy controls That study is striking because it used a national health database rather than self-reported outcomes, catching conditions that donors might not connect to their donation. The absolute mortality rate was still low (about 0.9 per 1,000 person-years among donors), but the relative increase compared to matched non-donors was hard to dismiss. The tension between these two bodies of evidence is worth keeping in mind: most donors do well, but “well compared to what” matters a great deal.
The Psychological Side of Donating
Every reputable transplant program screens potential living donors for psychological readiness, and this goes well beyond checking for obvious psychiatric conditions. One prospective study from a single academic center found that some degree of ambivalence was nearly universal among donor candidates, which researchers considered normal given the stakes. Stronger ambivalence surfaced in a smaller subset, and in one case was serious enough that the candidate was declined. Coercion by others was rare but occasionally subtle, taking the form of family members downplaying complications. A sense of moral obligation sometimes blurred into genuine moral responsibility in ways that were not easy to tease apart.10Journal of Liver Transplantation. Psychological screening and follow-up care for living liver donors: 5-year prospective cohort data from a single academic center
The ethical framework matters because liver donation is unusual among medical procedures: it is major surgery that provides no direct physical benefit to the patient on the operating table. The entire justification rests on the benefit to someone else and the donor’s autonomous wish to help. Programs use independent donor advocates, separate from the recipient’s medical team, to ensure the donor’s interests are protected throughout.
The Financial Reality for Living Donors
Medical costs of the donation surgery itself are typically covered by the recipient’s insurance. But that does not come close to covering the full financial picture. Potential living donors face indirect costs (lost wages, travel, childcare), direct out-of-pocket expenses, and opportunity costs, along with variable employer leave policies and the risk of insurance-based discrimination afterward.11PubMed Central. Financial toxicity in living donor liver transplantation: A call to action for financial neutrality
A prospective study within a major U.S. research cohort found that most donors reported cumulative out-of-pocket medical and non-medical expenses, and about 44% described those costs as burdensome. Lower income predicted feeling burdened, as did holding a non-professional job before donation.12PubMed Central. Social and Financial Outcomes of Living Liver Donation: A Prospective Investigation Within the Adult-to-Adult Living Donor Liver Transplantation Cohort Study 2 (A2ALL-2) The principle of “financial neutrality,” meaning that donors should not gain or lose money from the act of donating, is widely endorsed but inconsistently achieved. Some programs offer limited reimbursement for travel and lodging, and the U.S. National Living Donor Assistance Center provides grants, but coverage is uneven.
Deceased Donor Livers and How They Are Allocated
Most liver transplants still come from deceased donors. In the United States, allocation is governed by the MELD score (Model for End-Stage Liver Disease), which estimates a patient’s risk of dying while waiting. The sickest patients, those with the highest scores, are offered organs first within a defined geographic area.13PubMed Central. Current Status of Liver Allocation in the United States The score is capped at 40, which has created an equity problem: patients whose calculated MELD exceeds 40 have significantly higher waitlist mortality but are not further prioritized, even though their outcomes after transplant are comparable to patients at the cap.14PubMed Central. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease
Deceased donors fall into two categories based on how death is determined. Donation after brain death (DBD) has been the traditional standard. Donation after circulatory death (DCD), where death is declared based on cessation of heartbeat, has expanded the donor pool but comes with trade-offs. A large U.K. study found that five-year post-transplant survival was lower with DCD livers (about 69%) compared to DBD livers (about 78%).15PubMed. Survival advantage for patients accepting the offer of a circulatory death liver transplant A single-center comparison similarly found that DCD recipients were about 1.7 times more likely to lose their graft than DBD recipients, and DCD livers carried a higher rate of non-anastomotic biliary strictures, a particularly troublesome complication.16Transplant International. Comparison of Biliary Complications Rates After Brain Death, Donation After Circulatory Death, and Living-Donor Liver Transplantation: A Single-Center Cohort Study Nonetheless, for many patients on the waiting list, accepting a DCD liver leads to better survival than continuing to wait for a DBD organ.
Split Liver Transplantation
One way to stretch the deceased-donor supply is to split a single liver between two recipients. The more established approach divides the organ at the falciform ligament, yielding a left lateral segment graft (roughly 250 cc) for a child and a larger right trisegment graft (roughly 1,100 cc) for an adult.17American Journal of Transplantation. Split-liver transplantation Results from this technique have been comparable to whole-organ transplants for both the pediatric and adult recipient.18PubMed Central. Split liver transplantation
A more ambitious variant splits the liver into two roughly equal halves for two adults. This “full right/full left” approach could meaningfully expand the adult donor pool, but it demands a high level of surgical skill and detailed knowledge of anatomic variations.19PubMed Central. Split liver transplantation It remains uncommon and is performed mainly at high-volume centers.
Pediatric Liver Transplantation
Children pose a unique challenge because adult-sized livers are far too large for them. Left lateral segment grafts from either living donors or split deceased-donor organs are the standard approach. But for very small infants, even a left lateral segment can be too big, creating a “large-for-size” mismatch. Surgeons have addressed this by further reducing the graft’s thickness. At one major center in Tokyo, 131 infants who received these reduced-size grafts achieved a 15-year graft survival rate of about 90%.20PubMed Central. Reduced Size Liver Grafts in Pediatric Liver Transplantation; Technical Considerations
A meta-analysis comparing living-donor and deceased-donor pediatric liver transplants found no statistically significant differences in vascular or biliary complications between the two approaches.21PubMed Central. Living Donor Versus Deceased Donor Pediatric Liver Transplantation: A Systematic Review and Meta-analysis Living-donor transplants do offer the advantage of scheduling the surgery electively, avoiding the uncertainty of a waiting list, and using an organ from a healthy donor with minimal cold storage time.
Organ Preservation Is Getting Better
Traditionally, donated livers are flushed with a cold preservation solution and stored on ice, a method called static cold storage (SCS). This works well for many organs, but DCD livers are more vulnerable to the warm ischemia that occurs between cardiac arrest and organ cooling. Newer machine perfusion technologies pump oxygenated fluid through the liver during storage, either at body temperature (normothermic machine perfusion, or NMP) or at cold temperatures (hypothermic oxygenated perfusion, or HOPE).
A study comparing these approaches found that DCD livers treated with normothermic machine perfusion had the lowest rate of early allograft dysfunction at about 18%, compared to 50% for DCD livers stored on ice the traditional way. For DBD livers, the difference between machine perfusion and cold storage was not significant.22JAMA Surgery. Improved Outcomes and Resource Use With Normothermic Machine Perfusion in Liver Transplantation On the hypothermic side, a randomized trial demonstrated that HOPE reduced non-anastomotic biliary strictures from 18% to 6% in DCD liver transplants.23PubMed. Hypothermic Machine Perfusion in Liver Transplantation – A Randomized Trial A meta-analysis of multiple studies confirmed the benefit, finding that HOPE reduced overall biliary complications by about a quarter, though the effect was statistically significant only for DCD organs.24PubMed Central. Hypothermic oxygenated perfusion in liver transplantation: a meta-analysis of randomized controlled trials and matched studies
Mechanistically, what HOPE appears to do is protect the bile ducts from reperfusion injury, the damage that occurs when blood flow is restored after a period without oxygen. A study examining bile duct tissue found that ducts from livers preserved with hypothermic perfusion showed significantly less tissue death and gland damage after reperfusion compared to conventionally stored organs.25PubMed Central. Hypothermic oxygenated machine perfusion reduces bile duct reperfusion injury after transplantation of donation after circulatory death livers These preservation advances are shifting the calculus around DCD organs: livers that would once have been declined can now be transplanted with acceptable results.
What Happens After Transplantation for the Recipient
Receiving a new liver is not the end of treatment but the beginning of lifelong immunosuppression. The recipient’s immune system would attack the transplanted organ without medication to keep it in check. Modern protocols typically combine multiple drugs at different targets, allowing lower doses of each and fewer side effects than early-era regimens. The goal over time is to reduce immunosuppression to the minimum needed to prevent rejection.26PubMed Central. Basics and Art of Immunosuppression in Liver Transplantation The liver is somewhat more forgiving than other transplanted organs when it comes to rejection, which is one reason outcomes have improved so dramatically since the first successful transplant in 1967.27PubMed Central. Themes of liver transplantation
Immunosuppression carries its own risks: increased susceptibility to infections, higher rates of certain cancers over years and decades, kidney damage from the medications themselves, and metabolic issues like diabetes and high blood pressure. These trade-offs are manageable for most recipients, but they mean transplantation is a treatment, not a cure. Recipients need regular blood work, clinic visits, and ongoing medication adjustments for the rest of their lives.
Why Donation Rates Vary So Much Around the World
Global liver donation rates are shaped by policy, infrastructure, and culture in roughly equal measure. An analysis of OECD countries found that “opt-out” consent systems, where residents are presumed to consent to organ donation unless they register otherwise, were associated with significantly higher deceased donation rates than “opt-in” systems. Countries that allowed both brain-death and circulatory-death donors also had higher rates than those permitting only brain-death donation. Beyond policy, hospital bed density, higher education levels, and even charitable giving habits predicted donation rates.28PubMed Central. Factors influencing deceased organ donation rates in OECD countries: a panel data analysis
Cultural attitudes cut across geography in surprisingly consistent ways. Across Africa, Asia, and Europe, many people view the body after death as sacred and are reluctant to alter it. A general reluctance to discuss death openly also shows up in multiple regions, as do misconceptions about organ trafficking.29PubMed. Cultural Influences, Considerations, and Challenges for Organ Donation and Liver Transplantation Around the World Religious positions on organ donation vary widely within traditions, not just between them; most major religions have voices that endorse donation alongside voices that express reservations. The practical result is that donation rates are not simply a product of medical infrastructure but reflect deep social narratives about bodily integrity, trust in institutions, and what it means to give.
Xenotransplantation and the Future of Liver Supply
The organ shortage has pushed researchers toward more radical solutions. Xenotransplantation, transplanting organs from genetically modified pigs into humans, has been in the headlines recently after high-profile heart and kidney cases. Liver xenotransplantation is not as far along, but recent advances in genetic engineering have generated renewed optimism. Early milestones in pig-to-human heart and kidney transplants are paving the way for first-in-human clinical trials with livers.30PubMed Central. The Future of Pig Liver Xenotransplantation
The liver presents particular challenges for cross-species transplantation. It plays a central role in blood clotting, protein production, and immune regulation, and how a pig liver would handle all of those functions for a human body over months or years remains an open question. For now, the most likely near-term application may be using pig livers as a “bridge,” keeping a patient alive while they wait for a human organ, rather than as a permanent replacement. But if the field’s recent pace holds, the notion of an unlimited supply of transplantable livers may not remain science fiction for long.